跳至主要内容
临床试验/IRCT20091114002709N46
IRCT20091114002709N46已完成2 期

Study of the effect of oral quercetin supplement intake on mood in ß-thalassemia major patients

Iran University of Medical Sciences0 个研究点目标入组 84 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 40 years(—)
性别
All

入选标准

  • 18 to 40 year old male and female beta thalassemia major patients
  • Inclination to cooperate and signing the written informed consent
  • A minimum of 2 years of blood transfusion history
  • blood specimen collection 20 days after the last blood transfusion
  • Regular and peculiar iron-chelating therapy with desferrioxamine
  • Vitamin C supplement intake with desferrioxamine

排除标准

  • Uncontrollable and life threatening complication due to due to the supplement intake;; ; ; ; ; ;
  • A change in type or amount of the iron chelator
  • Pregnancy or lactation
  • Hepatitis infection and other metabolic or infectious diseases
  • Less than 80% compliance of supplement intake
  • Consumption of drugs that interfere with quercetin
  • Drinking more than 500 mg/day of beverages rich in flavonoids
  • Smoking or alcohol consumption

研究者

相似试验